Neuronetics, Inc.

NasdaqGM STIM

Neuronetics, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2024: -39.95%

Neuronetics, Inc. EBIT Margin is -39.95% for the Trailing 12 Months (TTM) ending September 30, 2024, a 12.22% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Neuronetics, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was -45.52%, a 13.64% change year over year.
  • Neuronetics, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was -52.71%, a -25.58% change year over year.
  • Neuronetics, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was -41.97%, a 20.50% change year over year.
  • Neuronetics, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was -52.79%, a -34.51% change year over year.
Key data
Date EBIT Margin EPS (Basic) EPS (Diluted) Shares (Basic, Weighted)
Market news
Loading...
SV Wall Street
NasdaqGM: STIM

Neuronetics, Inc.

CEO Mr. Keith J. Sullivan
IPO Date June 28, 2018
Location United States
Headquarters 3222 Phoenixville Pike
Employees 203
Sector Healthcare
Industries
Description

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Similar companies

BDSX

Biodesix, Inc.

USD 1.05

5.00%

XGN

Exagen Inc.

USD 5.33

6.17%

SERA

Sera Prognostics, Inc.

USD 5.04

1.61%

BNR

Burning Rock Biotech Limited

USD 6.68

-1.47%

FONR

FONAR Corporation

USD 16.20

3.45%

SHC

Sotera Health Company

USD 13.84

0.22%

StockViz Staff

February 6, 2025

Any question? Send us an email